UK Companies House feature
BIONICAL SOLUTIONS LIMITED
Cash
£931K
+682.4% vs 2019
Net assets
£2M
+467.1% vs 2019
Employees
368
+140.5% vs 2019
Profit before tax
£2M
+356.1% vs 2019
Profile
- Company number
- 04313379
- Status
- Active
- Incorporation
- 2001-10-30
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 62090
Net assets
2-year trend · vs UK AI & Enterprise SaaS median
Accounts
2-year trend · latest 2020-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 |
|---|---|---|---|
| Turnover | £8,665,000 | £22,009,000 | |
| Operating profit | -£507,000 | £2,683,000 | |
| Profit before tax | -£870,000 | £2,228,000 | |
| Net profit | — | — | |
| Cash | £119,000 | £931,000 | |
| Total assets less current liabilities | -£389,000 | £2,586,000 | |
| Net assets | -£426,000 | £1,564,000 | |
| Equity | £426,000 | £1,564,000 | |
| Average employees | 153 | 368 | |
| Wages | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company's business activities, together with the factors likely to affect its future development and position, are set out in the business review section of the strategic report on page 1. The financial statements have been prepared on the going concern basis which the Directors believe to be appropriate for the following reasons. The Directors have prepared cash flow forecasts for the continuing operations for a 12-month period from the date of approval of these financial statements and have concluded that the company can continue to meet its obligations as they fall due. The company is forecast to be profitable throughout the period which will lead to the company returning to a net asset position early in 2025. The investors remain fully supportive of the company.”
Significant events
- “During 2024, Bionical Solutions Limited hived down two business units (Bionical Health Limited and Bionical Virtual Engagement Limited) into new subsidiary companies. These subsidiaries were subsequently sold to Bionical Health Group Limited on 31 October 2024 and 30 November 2024 respectively.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BORKOWSKI, Andrew Thomas | Director | 2018-07-12 | Jun 1962 | British |
| DAVIES, Gareth | Director | 2018-07-12 | Oct 1968 | British |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DERMODY, Jayne Marie | Secretary | 2010-10-01 | 2015-09-29 |
| MCINTOSH, Graham | Secretary | 2016-04-14 | 2018-07-12 |
| RANDALL, Philip Michael | Secretary | 2002-04-04 | 2007-12-31 |
| COMBINED SECRETARIAL SERVICES LIMITED | Corporate Nominee Secretary | 2001-10-30 | 2002-04-04 |
| DERMODY, Jayne Marie | Director | 2010-10-01 | 2015-09-29 |
| DERMODY, Paul Malcolm | Director | 2004-01-14 | 2017-08-24 |
| JACKSON, Oliver Cameron | Director | 2003-04-06 | 2016-02-11 |
| JACKSON, Sian Bracken | Director | 2014-04-30 | 2015-09-29 |
| JAMES, Neil Gary | Director | 2002-04-04 | 2007-04-05 |
| MCINTOSH, Graham | Director | 2015-09-29 | 2018-07-12 |
| MILES, Helen | Director | 2018-07-12 | 2024-06-14 |
| MILLER, Robert | Director | 2003-04-06 | 2010-10-01 |
| RANDALL, Barbara Elaine | Director | 2010-10-01 | 2015-09-29 |
| RANDALL, Philip Michael | Director | 2002-04-04 | 2016-03-07 |
| COMBINED NOMINEES LIMITED | Corporate Nominee Director | 2001-10-30 | 2002-04-04 |
| COMBINED SECRETARIAL SERVICES LIMITED | Corporate Nominee Director | 2001-10-30 | 2002-04-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bionical Solutions Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 114 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-31 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-08-22 | AA | accounts | accounts with accounts type full |
| 2024-11-14 | AA | accounts | accounts with accounts type full |
| 2024-11-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-05 | ANNOTATION | miscellaneous | legacy |
| 2024-09-05 | ANNOTATION | miscellaneous | legacy |
| 2024-06-19 | TM01 | officers | termination director company with name termination date |
| 2023-10-30 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-09-25 | AA | accounts | accounts with accounts type small |
| 2023-09-05 | SH08 | capital | capital name of class of shares |
| 2023-09-05 | SH10 | capital | capital variation of rights attached to shares |
| 2023-08-16 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2023-08-08 | RESOLUTIONS | resolution | resolution |
| 2023-08-08 | MA | incorporation | memorandum articles |
| 2022-10-31 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-08-31 | AA | accounts | accounts with accounts type small |
| 2021-11-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-05-05 | AAMD | accounts | accounts amended with accounts type full |
| 2021-04-20 | AA | accounts | accounts with accounts type total exemption full |
| 2020-12-10 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ (private-firm) · reference 2020-12-31
2.56
GREY ZONE
Altman Z″
- Working capital / Total assets 0.151 × 6.56 = +0.99
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.212 × 6.72 = +1.42
- Book equity / Total liabilities 0.141 × 1.05 = +0.15
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory